hydroxyzine bluefish 10 mg
bluefish pharmaceuticals ab - hydroksyzinhydroklorid - tablett, filmdrasjert - 10 mg
terbinafin bluefish 250 mg
bluefish pharmaceuticals ab - terbinafinhydroklorid - tablett - 250 mg
dorzolamid/timolol sandoz 20 mg/ ml / 5 mg/ ml
sandoz - københavn - dorzolamidhydroklorid / timololmaleat - Øyedråper, oppløsning - 20 mg/ ml / 5 mg/ ml
fenylefrin aguettant 50 mikrog/ ml
laboratoire aguettant - fenylefrinhydroklorid - injeksjonsvæske, oppløsning i ferdigfylt sprøyte - 50 mikrog/ ml
otrivin 1 mg/ ml
haleon denmark aps - xylometazolinhydroklorid - nesespray, oppløsning uten konserveringsmiddel med mentol - 1 mg/ ml
carexarit 25 mikrog
2care4 generics aps - klonidinhydroklorid - tablett, drasjert - 25 mikrog
fenylefrin aguettant 100 mikrog/ ml
laboratoire aguettant - fenylefrinhydroklorid - injeksjons-/infusjonsvæske, oppløsning - 100 mikrog/ ml
zydelig
gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.
metopocor 1 mg/ ml
macure pharma aps - metoprololtartrat - injeksjonsvæske, oppløsning - 1 mg/ ml
xyrem
ucb pharma ltd - natriumoksybat - cataplexy; narcolepsy - andre nervesystemet narkotika - behandling av narkolepsi med katapleksi hos voksne pasienter.